Sanofi, a global leader in life science consulting, is making headway in Morocco, Tunisia, and Libya. Spearheaded by Adrien Delamare-Deboutteville, Sanofi’s mission is to enhance access to innovative therapies, reflecting the company’s commitment to value-based healthcare. This initiative aligns with Morocco’s grand vision of universal healthcare, a transformative goal that seeks to double the number of Moroccans covered by health insurance from 22 million to 44 million.
Innovation is at the heart of Morocco’s healthcare transformation. The country is making strides in integrating innovative therapies into their healthcare system, a testament to their commitment to improving patient outcomes. However, the journey is not without its challenges. It requires not only the development of innovative therapies but also the building of capabilities, competencies, and infrastructure. Sanofi is at the forefront of this movement, committed to bringing more innovative solutions to the market and ensuring they are integrated into the healthcare system.
Sanofi sets itself apart with its patient-first ethos. This approach was evident during the challenging period of war in Ukraine, where Delamare-Deboutteville and his team ensured the continuous operation of Sanofi’s Ukraine offices. Their dedication to their patients was paramount, demonstrating the resilience and commitment that defines Sanofi.
Their patient-centric approach is also evident in Morocco. Therefore, the company is keen to contribute to the evolution of Morocco’s healthcare ecosystem. They are working hand in hand with other stakeholders to implement the universal healthcare system. Sanofi’s strategy is built around bringing more innovation to the market. The company aims to transform the practice of medicine through breakthrough science, positively impacting people and communities. Their initiatives in Morocco include the My Child Matters program, supporting children with cancer, and the KiDS initiative, fostering a better understanding of diabetes in school environments.
In conclusion, the aspiration for future interactions is to ensure that the broader pharmaceutical industry, plays a pivotal role in shaping Morocco’s universal healthcare system. The ultimate goal is to become an integral part of this healthcare revolution in Morocco.
🚀 Discover how the AI-driven LabelComp tool is transforming drug safety surveillance! By automating the identification of adverse events in drug labelling, LabelComp enhances accuracy and efficiency, supporting regulatory decision-making and public health. 🌐💊
#SyenzaNews #AIinHealthcare #DrugSafety #PharmaInnovation #RegulatoryScience
🌟 School-based health centres (SBHCs) are improving healthcare for underserved youth across the US! These centres provide vital services, from preventive care to chronic disease management, right where students need them most – in schools. 📚🏥
SBHCs improve academic performance, reduce absenteeism, and enhance overall student well-being. Let’s support these essential centres and ensure every child has access to quality healthcare. 🌟
#SyenzaNews #SBHC #ChronicDiseaseManagement #HealthEquity #PreventiveCare
🌟 Exciting developments in Abu Dhabi! The Department of Health has introduced new ABA guidelines for Autism Spectrum Disorder, aiming to improve care for People of Determination. This initiative focuses on standardising care, enhancing accessibility, and fostering collaboration between healthcare and education professionals.
Learn more about how these guidelines can make a difference in the lives of individuals with ASD.
#SyenzaNews #HealthcareInnovation #AutismCare #InclusiveHealth #ABAGuidelines #AbuDhabiHealth
CORRESPONDENCE ADDRESS
WRITE US